TargetIng novel MEchanisms of Resolution in inflammation
The consortium identifies and validates new molecules involved in the resolution of inflammation, including natural and synthetic proresolving agents, as a basis for innovative therapies in chronic inflammatory and autoimmune diseases.
- EU contribution
- € 2,999,300
- duration
- 48 months
- coordinator
- Fondazione Humanitas per la Ricerca, Milan
- beneficiaries
- 10 partners